Table 2 |
||
|
Individual CVD risk factors and global CVD risk scores for patients in the cross-sectional study |
||
|
RA patients |
Number |
|
|
|
||
|
Individual CVD risk factors |
||
|
Age (years) |
56 ± 12 |
99 |
|
BMI (kg/m2) |
30 ± 6 |
99 |
|
SBP (mm Hg) |
133 ± 16 |
96 |
|
DBP (mm Hg) |
81 ± 10 |
96 |
|
Total cholesterol (mM) |
5.1 ± 1.0 |
93 |
|
HDL-C (mM) |
1.5 ± 0.3 |
93 |
|
Triglycerides (m) |
1.5 ± 0.7 |
93 |
|
TC/HDL ratio |
3.5 ± 8.5 |
93 |
|
Glucose (mM) |
4.6 (4.3-4.9) |
91 |
|
Insulin (pM) |
70.4 (40.6-105.5) |
89 |
|
HOMA IR |
2.1 (1.1-3.2) |
87 |
|
QUICKI |
0.35 ± 0.41 |
87 |
|
Cigarette-smoking status |
||
|
Never smoked |
38 (42) |
91 |
|
Previous smokers |
36 (40) |
91 |
|
Current smokers |
17 (19) |
91 |
|
Global CVD risk scores |
||
|
Framingham Risk Score |
5 (3-10) |
87 |
|
TC SCORE |
1 (0-2) |
64 |
|
TC/HDL SCORE |
1 (0-2) |
64 |
|
Reynolds Risk Score |
8 (3-14) |
65 |
|
QRISK 2 |
15 (7-26) |
95 |
|
|
||
|
Results are expressed as median (25th to 75th percentile values) or mean ± SD, as appropriate. BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; HOMA IR, homeostasis model assessment insulin resistance; QUICKI, quantitative insulin sensitivity check index; SBP, systolic blood pressure; SCORE, systematic coronary risk evaluation; TC, total cholesterol. |
||
|
Sandoo et al. Arthritis Research & Therapy 2012 14:R117 doi:10.1186/ar3847 |
||
